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Summal'y 
The homing of blood borne lymphocytes into lymph nodes and Peyer's patches is mediated in 
part by recognition and binding to specialized  high endothelial venules (HEV). Here we demonstrate 
that a rapid pertussis toxin-sensitive lymphocyte activation event can participate in lymphocyte 
recognition of HEV. In situ video microscopic analyses of lymphocyte interactions  with HEV 
in exteriorized mouse Peyer's patches reveal that pertussis toxin has no effect on an initial "rolling" 
displayed by many lymphocytes, but inhibits an activation-dependent  "sticking" event required 
for lymphocyte arrest. This is the first demonstration that physiologic lymphocyte-endothdial 
interactions can involve sequential roiling, activation, and activation-dependent  arrest, previously 
shown only for neutrophils.  The inhibitory effect of the toxin is dependent on its G protein- 
modifying ADP-ribosyltransferase activity and can be reversed by phorbol myristic acetate, which 
bypasses cell surface receptors to trigger activation-dependent  adhesion.  Lymphocyte sticking 
can occur within 1-3 s after initiation of roiling. We conclude that a rapid receptor-mediated 
activation event involving G protein signaling can trigger stable lymphocyte attachment to HEV 
in vivo, and may play a critical role in regulating lymphocyte homing. 
T 
he traffic of lymphocyte subsets is directed by binding to 
specialized  venules, especiaUy  the high endothelial venules 
(HEV) in lymphoid tissues and in sites of inflammation (1, 
2). These interactions display tissue selectivity that has been 
explained in part by the description  of lymphocyte homing 
receptors capable of binding to tissue-sdective endothelial cell 
adhesion receptors, the vascular addressins (3). Additional com- 
plexity in the regulation of lymphocyte--endothelial cell (EC) 
recognition is implied, however, by the observation that adhe- 
sion pathways used by lymphocytes can also be used in other 
physiologic settings, for example, by neutrophils interacting 
with acutely inflamed endothelium. Recently, we and others 
have proposed a model of leukocyte-EC interaction as an ac- 
tive, muhistep process in which stable binding to the en- 
dothelium involves at least three sequential events (4, 5). In 
this model, interaction is initiated by primary,  activation- 
independent but unstable  adhesion that serves to slow the 
passage of the leukocyte allowing sampling of the EC sur- 
face and of any local soluble factors. If activating factors are 
present to which the leukocyte can respond,  activation (the 
second  step) occurs,  leading to  triggering  of activation- 
dependent adhesion receptors. Binding of activation-dependent 
adhesion receptors to their EC ligands results in stable binding, 
resistant  to physiologic shear, thus completing the process 
of "recognition" Additionally, the recruitment of the bound 
leukocyte from the vessel wall into the surrounding tissues 
may be regulated independently of leukocyte-EC recogni- 
tion mechanisms, for example by tissue-derived chemoattrac- 
tant or haptotactic  signals. The requirement for sequential 
engagement of primary adhesion, activation, and secondary 
adhesion pathways allows the possibility of regulating leu- 
kocyte-EC recognition at each of the three steps involved. 
However, the central features of the three-step model have 
been confirmed experimentally only in the case of neutrophil 
interactions  with acutely inflamed venules in the rabbit,  in 
which a primary "rolling" interaction involving the leuko- 
cyte selectin is followed by an activation-dependent "sticking" 
and arrest mediated by ~2 (CD18) integrins (6-8). Intravital 
microscopic studies, as well as in vitro models of neutrophil 
interactions with vascular adhesive ligands, demonstrate that 
under physiologic shear, each of the three steps is required 
for completion of the recognition process and for stable ar- 
rest of neutrophils (9, 10). We have suggested that a similar 
process might be used by other leukocytes, including lym- 
phocytes (4). However, although in vitro studies demonstrate 
that lymphocytes can be triggered by activation to upregu- 
late adhesion molecules, including integrins, the kinetics of 
such in vitro activation-dependent  adhesion seem too slow 
(occurring over minutes) to explain the extremely rapid in- 
teractions of circulating lymphocytes with HEV in vivo, which 
occur within seconds (4,  11). 
The present study was designed to explore directly the rel- 
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the involvement of  lymphocyte  activation in lymphocyte-HEY 
interactions, using pertussis toxin (PTX) as a tool. The ra- 
tionale for this approach was based on two considerations. 
First, many chemoattractant factors that are capable of trig- 
gering activation-dependent adhesion of leukocytes act via 
PTX-sensitive  G  protein-mediated intracellular  signaling 
pathways. Second, Huang et al. (12) demonstrated that PTX- 
treated lymphocytes home poorly into lymph nodes from the 
blood in spite of retaining a capacity to bind in in vitro assays 
to lymph node HEV via the (activation-independent) lymph 
node homing receptor,  the t-selectin. These considerations 
led us to hypothesize that a PTX-sensitive signal transduc- 
tion pathway might play an essential role in lymphocyte-HEV 
recognition and binding in vivo. 
Materials and Methods 
Sample Lymphocyte Preparation.  Peripheral  and mesenteric  lymph 
node lymphocytes  from young adult BALB/c  mice (Simonsen  Labs, 
Gilroy, CA) were suspended at a concentration of 5  x  106/ml in 
DMEM (without sodium bicarbonate [Sigma Chemical Co., St. 
Louis, MO] supplemented with 20 mM Hepes, pH 7.0 (Research 
Organics,  Cleveland, OH)],  and  containing  1  or  4%  iron- 
supplemented calf serum (HyClone Labs, Logan, UT), and were 
incubated at 37~  with or without PTX (100 ng/ml; List Biolog- 
ical Labs, Campbell, CA) for 2 h. In some experiments, a mutant 
pertussis holotoxin (PT9K 129G) was used. This mutant PTX re- 
tains the agglutinating, hemolytic, and antigenic properties of na- 
tive lyrx, and gave  indistinguishable  subunit banding patterns with 
native PTX (13, 14) when compared by SDS-PAGE and Coomassie 
staining. During the last 30 min of incubation, the cells were la- 
beled with either FITC at 60/~g/ml in DMEM, 4% calf serum 
as described (15), or with 5-carboxyfluorescein  diacetate (CFDA- 
AM; Molecular Probes, Eugene, OR) used at a 1:4,000 dilution 
from a 1-mg/ml stock in DMSO in DMEM, 1% serum. Alterna- 
tively, after 2 h  at  37~  calls were labeled for 20 min with 
tetramethylrhodamine isothkx-yanate (TRITC; Sigma Chemical 
Co.) at 1.7 #g/ml in 4% serum at room temperature. Labeled  cells 
were washed through a calf serum cushion and resuspended at ,,o5 
x  107/ml in DMEM for intravenous injection. In some instances, 
PMA (Sigma Chemical Co.) was added to a 100-ng/ml final  con- 
centration, and cells were incubated an additional 5 min at 37~ 
immediately  before injection. This brief treatment does not down- 
regulate L-selectin homing receptor expression. 
In Situ Video Microscopic  Analyses of Lymphocyte-HEV Interactions. 
Syngeneic recipients were anesthetized, and an aseptic abdominal 
incision was made to exteriorize the small intestine and Peyer's 
patches. A selected patch was embedded in silicon high-vacuum 
gel (Dow Corning, Midland, MI) to provide a matrix allowing 
application of a coverslip and positioning for epifluorescence  mi- 
croscopy and video recording using a silicon-intensified  target video 
camera (Cohu, San Diego, CA). The small intestine was bathed 
in freshly made Dulbecco's PBS at 37~  The recipient was main- 
tained at 37~  by a stage-mounted strip heater regulated via a tem- 
perature probe beneath the mouse. 
Approximately 2.5  x  107 hbded cells in 0.5 ml DMEM were 
injected intravenously into the recipients' lateral tail vein. Injected 
cells were then observed and recorded entering and interacting with 
Peyer's patch HEV for the duration of each experiment. In many 
experiments both the experimental and control calls of different 
colors were injected,  observed, and interactions  recorded  in the same 
Peyer's patch HEV. Because there is a transient increase in blood 
flow immediately  after injection, and because the Peyer's  patch often 
requires minor repositioning to focus on HEV, data analyses  were 
routinely initiated "~30 s after infusion of sample cells and con- 
tinued during the next 2.5 min. Evaluation of the interactions of 
individual cells was carried out by replaying the video recording 
on a four-head VCR with shuttle wheel single frame forward and 
reverse control 0VC, Elwood Park, NJ). Initial control experiments 
showed no significant differences in the in vivo behavior of cells 
labeled with TRITC, FITC, or CFDA. 
Analyses of Lyraphocyte Behavior.  The behavior traces are plots 
of  distance moved along an HEV from the site of  initial interaction 
vs. time in seconds after the initial interacting contact. The posi- 
tion of each selected cell was determined by analysis  of the video 
image at 0.33-s intervals from the time and site of initial interac- 
tion, until the cell either released to the circulation ("passed;' with 
the cell trace exiting the plot vertically),  or became stably attached 
at a given site on the HEV wall ("arrested" with the trace exiting 
the plot horizontally).  Note that a typical  noninteracting cell  would 
pass completely through an HEV in g0.66 s. 
For frequency plots summarizing population behaviors, a rapid 
procedure for quantifying the motion of  cells was used. Individual 
cells were analyzed on a second-by-second  basis for 5 s after initia- 
tion of interaction or until the cell passed from the HEV. Each 
1-s period of interaction was assigned a value of 0 for sticking be- 
havior, defined  arbitrarily as static binding to the HEV wall during 
at least two consecutive seconds; or of 1, indicating predominant 
rolling interaction including "stop-and-go" behavior with static 
binding of <1 s. If during an interaction sequence a cell "skipped" 
releasing transiently from the vessel wall, only the time interval 
during which rolling or sticking took place was scored. For each 
cell, the values assigned to each second of interaction were aver- 
aged, yielding a time-averaged  indicator of the cells' mean behavior. 
Inherent in this scoring procedure is a bias toward more interactive 
behaviors, so that the very brief <l-s initial rolling displayed  by 
many PMA-preactivated  lymphocytes  (illustrated in Fig. 1 e) is not 
reflected in the mean score. In most experiments, at least 20 lym- 
phocytes interacting with two to three or more independent dis- 
tinct HEV were scored. The histograms present the relative  distri- 
bution of behaviors among normal, FTX-treated, and FTX plus 
PMA-treated lymphocyte populations from three to five separate 
animals for each treatment type. 
Results and Discussion 
Lymphocyte  interactions with HEV, specialized vessels that 
support lymphocyte  extravasation into lymphoid tissues, can 
be visualized in the mouse by intravital microscopy of exteri- 
orized Peyer's patches (11). Fluorescence-labeled lymphocytes 
are injected intravenously, and their interaction with Peyer's 
patch HEV is observed and recorded by video epifluorescence 
microscopy.  We analyzed the in situ behavior of lymph node 
lymphocytes between ~30 s and 3 min after intravenous in- 
jection. 
Individual lymphocytes displayed wide variability in be- 
havior.  Many interacted transiently with  the  HEV,  then 
released only to interact again further downstream, as de- 
scribed by Bjerknes et al. (11). During periods of interaction, 
some lymphocytes "rolled" along the venule without stop- 
ping, others (the majority) rolled a variable distance before 
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Figure  1.  In situbehavior  ofin- 
jeeted normal, PTX-treated, and 
PTX plus PMA-treated lympho- 
cytes during interaction with Peyer's 
patch  HEV. Behavior traces of 
selected  individual lymphocy~ (/eft) 
and histograms of the frequency  of 
time-averaged lymphocyte  behaviors 
(right) illustrate the varied behavior 
of normal lymphocytes  (a and b), 
the predominant rolling phenotype 
of PTX-treated lymphocytes  (b and 
c), and the rapid sticking behavior 
of PTX plus PMA-treated cells (e 
and J). The histograms (right) pre- 
sent pooled  analyses  of three to five 
experiments for each treatment (see 
Materials and Methods). Lympho- 
cytes  were  treated as described  in the 
legend to Table 1 and in Materials 
and Methods. 
stopping either briefly (<1 s, termed "stop-and-go behavior") 
or longer (>1 s, termed "sticking"). Overall, '~35% arrested 
stably, attaching statically to the vessel wall for i>5 s (Table 
1). The detailed behavior of several individual lymphocytes 
is displayed in Fig.  1 a  as a plot of distance traveled from 
the site of initial interaction with the vessel wall vs. the elapsed 
time. A  histogram summarizing  the frequency of lympho- 
cytes  displaying  predominant  rolling,  mixed  (rolling  and 
sticking), or predominant  sticking behaviors is presented in 
Fig.  1 b. The data illustrate  the variability of normal lym- 
phocyte interactions. 
To determine the effect of PTX, lymphocytes were incubated 
with PTX (100 ng/ml for 2 h at 37~  before injection. PTX- 
treated lymphocytes interacted with the same frequency as 
normal cells, but demonstrated a striking reduction in stable 
arrest (Table 1). Most importantly,  the character of interac- 
tion was altered dramatically,  consisting almost exclusively 
of rolling with interspersed stop-and-go behavior (illustrated 
in Fig.  1 c), with static interactions  rarely exceeding I  s in 
duration.  Fig.  1 d emphasizes the almost exclusive rolling 
behavior of FFX-treated lymphocytes. Thus, PTX treatment 
appears to uncouple physiologically a primary rolling pheno- 
type from a Fl'X-sensitive  sticking  and arrest. 
To rule out nonspecific toxicity, we next asked if we could 
reverse  the  inhibitory  effect  of Irl'X  with  PMA,  which 
can directly stimulate protein kinase C  (PKC) and trigger 
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Cell treatment 
Control  PTX  PTX  +  PMA 
Percent of cells entering HEV that interact 
Percent of interacting cells: 
That return to the blood (pass) 
That arrest (>5  s) 
84  +  3  88  _+  3  88  +  4 
66  _+  4  95  +  2  28  +  6 
34  +  4  5  +  4  72  +  4 
Percentage  of injected fluorescence-tagged  lymphocytes  entering FIEV that interact with the vessel wall, and of interacting lymphocytes  that return 
to the circulation  (pass) or interact stably (>5 s). For the data,  all cells interacting with selected HEV during some or all of the observation  period 
were analyzed.  Similar results  were obtained  in three to five independent  animals for each cell treatment,  and  the data  are pooled and  expressed 
as the percent  of cells displaying  the indicated  behavior,  with the standard  error. Lymph node cells were incubated  with 100 ng/ml PTX for 2 h 
at 37~  immediately before injection. Control cells were incubated  in parallel in medium for 2 h at 37~  For PTX plus PMA treatment,  PMA 
was  added  to a  100-ng/ml final concentration during the last  5 min of incubation  with PTX. 
activation-dependent lymphocyte adhesion (16). trFX-treated 
lymphocytes pulsed with PMA for 5 min just before injec- 
tion demonstrated restored and even enhanced sticking and 
arrest (Table 1 and Fig. 1, e andJ). Lymphocytes treated with 
PMA alone behaved similarly (not shown). Although PKC 
does not appear to play a critical role in physiologic lympho- 
cyte-HEV interactions (12), the ability of PKC stimulation 
to mimic the effects of in vivo activation, and to circumvent 
the inhibition of sticking by PTX, suggests that PTX does 
not interfere with sticking mechanisms directly but rather 
may block an activation pathway that triggers these mech- 
anisms. 
PTX ADP-ribosylates sensitive G proteins, interfering with 
G  protein-mediated signal  transduction from cell  surface 
receptors (17). A  mutant pertussis holotoxin, specificaUy 
lacking ADP-ribosyltransferase activity by virtue of two amino 
acid substitutions in the $1 subunit (13, 14), had no effect 
on the in vivo behavior of lymphocytes (Fig. 2). The results 
suggest that lymphocyte sticking and arrest is triggered by 
an activation event mediated or regulated by PTX-sensitive 
G proteins. 
Under physiologic conditions, this activation event may 
occur while lymphocytes are roUing along the endothelium. 
Consistent with this hypothesis, normal lymphocytes take 
longer to stick and arrest than PMA-preactivated cells (Fig. 
1, a and e). Physiologic activation and triggering of shear- 
resistant adhesion receptors must nonetheless occur surpris- 
ingly rapidly. The mean interaction time before sticking of 
those normal lymphocytes that go on to arrest stably is only 
'~1-3 s (mean, 1.3 s; range, 0.2-4 s, n  =  58 lymphocytes 
from five experiments). In keeping with such a rapid change 
in adhesive state, Bjerknes (11) reported a fairly abrupt in- 
crease between 1 and 3 s in the probability that an interacting 
cell would bind stably. 
It should be emphasized that the conclusions here are drawn 
from the behavior displayed by the majority of injected lymph 
node lymphocytes. The fact that most lymphocytes interact 
with Peyer's patch HEV, and that a significant  fraction of 
them adhere, is consistent with previous studies demonstrating 
that the major populations of B and T lymph node lympho- 
cytes home well to organized lymphoid tissues, including the 
Peyer's patches (18). Less abundant subsets of lymphocytes, 
particularly memory and blast cell subsets,  which can dis- 
play highly tissue-selective homing properties, may behave 
differently (2). In particular,  it will be important to deter- 
mine if lymphoblasts returning to the circulation after local 
antigenic stimulation may (like PMA-preactivated cells) be 
able to stick and arrest on HEV independent of the receptor- 
mediated vessel-associated activating signals implied by the 
current studies.  Indeed, a small subset of normal lympho- 
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Figure  2.  In situ behavior oflymphocytes pretreated with an enzymat- 
ically inactive pertussis holotoxin. The distribution of behaviors of lym- 
phocytes treated with the mutant toxin is not significantly different from 
that of untreated  control lymphocytes  (Fig. 1 b). Procedures were as for 
Fig. 1, c and d (see Materials and Methods),  except that a purified mutant 
holotoxin (PTgK  129G), specifically lacking ADP-ribosyltransferase  ac- 
tivity, was used. Results are from a representative experiment  of five per- 
formed  with the mutant  toxin. 
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pecially during the initial 30-s period of stabilization  after 
intravenous injection (not included in the quantitative studies 
presented). These may represent such preactivated lympho- 
cytes among the mesenteric lymph node lymphocyte popu- 
lation. 
G protein signaling pathways appear well suited to the very 
rapid alterations in cellular behavior required for lymphocyte 
sticking to HEV under physiologic flow conditions. Cellular 
activation through G protein-linked receptors can be extraor- 
dinarily rapid, with global effects on cellular activities. Ex- 
amphs include the rapid depolarization  of retinal neurons 
by photo activation of rhodopsin; and perhaps more relevant, 
stimulation of the aggregation of neutrophils within seconds 
after triggering of the FMLP receptor. Lymphocytes  are known 
to use FFX-sensitive  G proteins  to transduce  signals from 
a number of cell surface  receptors, notably including receptors 
for cytokines of the chemokine family (19-21), which have 
been hypothesized to play a role in regulation of lympho- 
cyte-endothelial interactions  (4). The hypothesized role of 
chemokines in lymphocyte-endothelial recognition has re- 
ceived additional support from the recent demonstration that 
members of the chemokine family can bind to and be dis- 
played at the lumenal surface of venules involved in leuko- 
cyte or lymphocyte traffic (22, 23).  Chemokines are also 
thought to be important in lymphocyte  chemotaxis through 
tissues (19-21), and may be able to regulate diapedesis in- 
dependently of the rapid activation of HEV binding studied 
here. Crosslinking of some lymphocyte  surface receptors can 
also trigger activation-dependent lymphocyte  adhesion mech- 
anisms (reviewed in reference 5),  and it will be important 
to determine if these activating pathways also involve G pro- 
tein-mediating signaling. 
In conclusion, our results demonstrate that a rapid activa- 
tion-dependent adhesion event involving FFX-sensitive G pro- 
teins can participate in lymphocyte-HEV  interactions, leading 
to stable arrest of  lymphocytes under shear flow. For the major 
population of unactivated lymph node lymphocytes studied 
here, this activation-dependent  sticking appears to follow a 
primary rolling interaction that may allow these lymphocytes 
to receive stimulating signals by initiating contact with the 
endothelium and slowing their passage. Our findings are com- 
patible with in vitro studies suggesting that PTX can inhibit 
activation-dependent  participation  of the integrin LFA-1 in 
lymphocyte  binding to lymph node HEV in frozen sections 
(24). The observations establish a strong parallel with similar 
cellular events  involved  in neutrophil interactions  with inflamed 
endothelium (4, 6-10,  25), and support a general model of 
leukocyte-EC  interaction as a multistep process (4, 5). In this 
model, the local factors responsible for lymphocyte activa- 
tion may assume equal importance with lymphocyte  homing 
receptors and vascular addressins in determining the specificity 
of lymphocyte-HEV interactions  and lymphocyte homing 
in organized lymphoid tissues and sites of inflammation. 
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